R&D Partner Content 10th Innate Killer Summit With recent expansion into autoimmune pipelines, the year of the ‘bounce back’ now feels in reach for the NK space.
R&D Partner Content 9th Commercialising Continuous Processing Summit 2025 The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development.
Oncology Partner Content 9th Liquid Biopsy for Precision Oncology Summit 9th Liquid Biopsy for Precision Oncology Summit | February 18-20, 2025 | San Diego, CA | FREE* to Attend for Biopharma
R&D Partner Content Returning... The 5th Operationalize Expanded Access Programs... Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
R&D Partner Content LEAP HR: Life Sciences Europe Save the Date for LEAP HR: Life Sciences Europe! 18th-20th February, 2025, London, UK.
Patients Partner Content Patient Recruitment for Rare Disease Trials Summit Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.